Rephonic
Artwork for ASCO Daily News
Immunotherapy
Breast Cancer
Lung Cancer
ASCO Annual Meeting
Artificial Intelligence
Clinical Trials
Oncology
Colorectal Cancer
Multiple Myeloma
Prostate Cancer
Cancer Care
Chemotherapy
Neoadjuvant Therapy
Acute Myeloid Leukemia
Melanoma
Circulating Tumor DNA
Non-Small Cell Lung Cancer
Pembrolizumab
Gastrointestinal Cancers
Ovarian Cancer

The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.

PublishesWeeklyEpisodes277Founded11 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for ASCO Daily News

Latest Episodes

Dr. Marco Ruella joins Dr. Monty Pal to discuss landmark 10-year follow-up data on tisa-cel CAR T-cell therapy for B-cell lymphomas, as well as emerging advances in dual-targeted CARs and their shift into earlier lines of treatment.

LINK TO FULL TR... more

Dr. Ryan Nipp joins Dr. Monty Pal to discuss the high-impact cancer care delivery research presented at the 2026 ASCO Quality Care Symposium, including studies on financial navigation and decentralized clinical trials.

LINK TO FULL TRANSCRIPT

Dr. Sara Tolaney joins Dr. Monty Pal to discuss optimizing the sequencing and combination of antibody-drug conjugates for metastatic HER2-positive and triple-negative breast cancer, as well as guidelines for managing serious toxicities like ILD and n... more

Myeloma specialists Dr. Marc Braunstein and Dr. Rahul Banerjee join Dr. Monty Pal to discuss recent breakthroughs for patients with multiple myeloma, including expert advice on how to manage side effects and identify the right treatment among a serie... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
Journal of Clinical Oncology (JCO) Podcast
Journal of Clinical Oncology (JCO) PodcastAmerican Society of Clinical Oncology (ASCO)
ASCO Guidelines
ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)
ASCO Education
ASCO EducationAmerican Society of Clinical Oncology (ASCO)
NEJM This Week
NEJM This WeekNEJM Group

Recent Guests

Ryan Nipp
GI medical oncologist and cancer outcomes researcher at the University of Oklahoma
University of Oklahoma
Episode: Highlights From the 2026 ASCO Quality Care Symposium w/ Dr. Ryan Nipp
Sara Tolaney
Chief of breast oncology at Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School
Dana-Farber Cancer Institute
Episode: ASCENT and DESTINY-Breast09 Trials: Applying Frontline Data in Metastatic Breast Cancer Care
Marc Braunstein
Associate Professor of Medicine at NYU; practices in Mineola at NYU Grossman Long Island School of Medicine
New York University (NYU)
Episode: CAR T Cells and Bispecific Antibodies: Navigating the New Era in Multiple Myeloma Management
Rahul Banerjee
Associate Professor at the Fred Hutch; focuses on talks management and patient experience in myeloma
Fred Hutchinson Cancer Research Center
Episode: CAR T Cells and Bispecific Antibodies: Navigating the New Era in Multiple Myeloma Management
Jedd Wolchok
Meyer Director of the Sandra and Edward Meyer Cancer Center at the Weill Cornell Medicine; attending oncologist
Weill Cornell Medicine, NewYork-Presbyterian
Episode: Are We Curing Advanced Melanoma? A Conversation With Dr. Jedd Wolchok
Petros Grivas
Professor of Medicine, University of Washington; Medical Director of the International Program and Local/Regional Outreach; Clinical Research Division at Fred Hutch
University of Washington; Fred Hutchinson Cancer Center
Episode: Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities
Regina Barragán-Carrillo
Geomedical Oncologist and Clinical Researcher at Mexico's National Cancer Institute
National Cancer Institute, Mexico
Episode: How Do We Translate ASCO26 Research Into Practice in Latin America?
Rachna Shroff
Chief of the division of Hematology and Oncology, University of Arizona College of Medicine, Tucson; Professor of Medicine; endowed professor of GI oncology
University of Arizona College of Medicine
Episode: GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?
Atul Batra
Professor of Medical Oncology at All India Institute of Medical Sciences (AIIMS), New Delhi
AIIMS New Delhi
Episode: From Abstract to Action: Translating ASCO26 Research Into Global Practice

Host

Monty Pal
Primary host of the show, physician-scientist with affiliations at City of Hope (Los Angeles) and related ASCO Daily News leadership.

Reviews

4.7 out of 5 stars from 135 ratings
  • Accessible high yield content

    As a medical resident, I’m impressed by how this podcast is able to offer expert-driven insights into the cutting edge of oncology without losing listeners in the weeds of a highly specialized topic. These episodes are concise, charismatically delivered, and fascinating.

    Apple Podcasts
    5
    Leigh_k_k
    United States10 months ago
  • No help to practice. Agenda driven.

    None of this helps me in my practice. It seems like an agenda driven outlet with very little, if any practice changing information.

    Apple Podcasts
    1
    D0ct0r.J
    United States4 years ago
  • Advanced prostrate cancer

    Exceptional research done by these doctors and researchers- someone in my family has advanced prostrate cancer - which has moved into hip bone.

    It is so scary .

    Right now he’s on hormone therapy . To reduce the size of the gland.

    He’s 84 and is in excellent health.

    He’s in Carmel so if there are trials or anything else I’d love to pass the information on to him.

    After listening to this podcast I am excited about the novel studies /trials on the horizon .

    The fact that many cancer patie... more

    Apple Podcasts
    5
    dinar320
    United States4 years ago
  • Ask for the draft of the program

    Would you please give us the draft of this program!Thanks a lot!

    Apple Podcasts
    5
    猫小猫2009
    China6 years ago
  • Dr.James Gulley

    Thank you for this informative and reassuring podcast. The interviewer allowed Dr. Gulley lots of time to share his knowledge and asked only relevant questions. More like this please.

    Apple Podcasts
    5
    JJGeneva
    United Kingdom7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Strong appreciation for accessible explanations of complex trials and data.
Concise, high-yield oncology content with expert-driven insights.
Guest mentions like Dr. Gulley are praised for relevant questions and depth.
Host changes are well-received and improve the intimate understanding of cancer topics.
Listener notes call for more practical guidance; some feel content is agenda-driven.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Highlights From the 2026 ASCO Quality Care Symposium w/ Dr. Ryan Nipp
Q: What were your main takeaways from this?
Decentralized trials could reduce travel and other patient burdens, but implementation requires regulatory clarity, operational infrastructure, trained staff, physician champions, and strategies suited to each site's capabilities and patient population.
Highlights From the 2026 ASCO Quality Care Symposium w/ Dr. Ryan Nipp
Q: Can you tell us about this study and what it really sort of highlights in terms of operational bottlenecks?
The study found practical and financial obstacles to billing for navigation, including consent requirements, payer coverage, technology challenges, and too few patients accumulating enough qualifying time. Potential changes include loosening the timing and consent rules, increasing payment, and reducing patient out-of-pocket costs.
ASCENT and DESTINY-Breast09 Trials: Applying Frontline Data in Metastatic Breast Cancer Care
Q: Any pearls regarding toxicity management with sacituzumab govitecan, particularly diarrhea and neutropenia?
High-grade neutropenia is common, while high-grade diarrhea is rare. Primary growth-factor prophylaxis is appropriate for patients with risk factors, and schedules may combine short-acting support after day one with long-acting support after day eight.
ASCENT and DESTINY-Breast09 Trials: Applying Frontline Data in Metastatic Breast Cancer Care
Q: In your practice, how do you decide between the doublet of trastuzumab deruxtecan plus pertuzumab versus trastuzumab deruxtecan alone?
The combination is the approved first-line option because it met the trial's interim significance threshold, while the monotherapy arm remains blinded pending the primary progression-free survival analysis. Most patients currently receive the combination, with treatment choices otherwise guided by clinical factors.
CAR T Cells and Bispecific Antibodies: Navigating the New Era in Multiple Myeloma Management
Q: How does the new era of therapies represent a sea change from the triple regimens used previously in multiple myeloma?
The shift is towards using CAR T and bispecifics earlier in the disease course, which not only improves functional status and disease control but also opens the possibility of longer remissions and potential cures in a subset of patients.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About ASCO Daily News

What is ASCO Daily News about and what kind of topics does it cover?

A clinically focused podcast landscape with a heavy emphasis on cutting-edge oncology research, trial results, and practical implications for patient care. Episodes consistently analyze ASCO findings across GI, GU, breast, and hematologic cancers, often pairing conference data with expert interpretation to translate evidence into clinical decision-making. A notable strength is the breadth of topics—from novel targeted therapies and cellular treatments to real-world access and sequencing considerations—delivered by practicing oncologists and researchers who frequently contextualize data for diverse healthcare settings. The show is particularly valuable for clinicians, researchers, and industry professionals seeking concise, expert-driven ins... more

Where can I find podcast stats for ASCO Daily News?

Rephonic provides a wide range of podcast stats for ASCO Daily News. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to ASCO Daily News and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does ASCO Daily News get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for ASCO Daily News, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for ASCO Daily News?

Rephonic provides comprehensive predictive audience data for ASCO Daily News, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does ASCO Daily News have?

To see how many followers or subscribers ASCO Daily News has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to ASCO Daily News?

These podcasts share a similar audience with ASCO Daily News:

1. Two Onc Docs
2. Journal of Clinical Oncology (JCO) Podcast
3. ASCO Guidelines
4. ASCO Education
5. NEJM This Week

How many episodes of ASCO Daily News are there?

ASCO Daily News launched 11 years ago and published 277 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact ASCO Daily News?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for ASCO Daily News?

Rephonic pulls ratings and reviews for ASCO Daily News from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for ASCO Daily News?

Rephonic provides full transcripts for episodes of ASCO Daily News. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on ASCO Daily News?

Recent guests on ASCO Daily News include:

1. Ryan Nipp
2. Sara Tolaney
3. Marc Braunstein
4. Rahul Banerjee
5. Jedd Wolchok
6. Petros Grivas
7. Regina Barragán-Carrillo
8. Rachna Shroff

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days